Clinical Trial Update: Ramosetron, Aprepitant and Dexamethasone Versus Ondansetron, Aprepitant and Dexamethasone [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical trial comparing Ramosetron plus Aprepitant and Dexamethasone versus Ondansetron plus Aprepitant and Dexamethasone in cancer patients;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Decadron (Dexamethasone)
• EMEND (aprepitant)
• Ramosetron (ramosetron)
• Zofran (Ondansetron)

Snippet

Sponsor: Hallym University Medical Center | Conditions: Cancer, Malignancy | Phase 3 | Status: UNKNOWN